doi: 10.1111/j.1365-2133.1947.tb10871.x.
Calciferol treatment of lupus vulgaris
- PMID: 20268338
- DOI: 10.1111/j.1365-2133.1947.tb10871.x
Item in Clipboard
Calciferol treatment of lupus vulgaris
Br J Dermatol Syph.
1947 Oct.
No abstract available
Similar articles
-
Calciferol (vitamin D2) in the treatment of lupus vulgaris.Ir J Med Sci. 1947 May;(257):211-4. Ir J Med Sci. 1947. PMID: 20251966 No abstract available.
-
Lupus vulgaris, resistant to calciferol; treated with streptomycin and calciferol.Proc R Soc Med. 1949 Aug;42(8):571. doi: 10.1177/003591574904200802. Proc R Soc Med. 1949. PMID: 18138750 Free PMC article. No abstract available.
-
Lupus vulgaris treated with calciferol.Proc R Soc Lond B Biol Sci. 1946 Mar;39:225-7. Proc R Soc Lond B Biol Sci. 1946. PMID: 21024124 No abstract available.
-
Treatment of lupus vulgaris with calciferol.Br J Dermatol Syph. 1946 Mar-Apr;58:45-52. doi: 10.1111/j.1365-2133.1946.tb16275.x. Br J Dermatol Syph. 1946. PMID: 21027646 No abstract available.
-
The effects of calciferol and its metabolites on patients with chronic renal failure. I. Calciferol, dihydrotachysterol, and calcifediol.Arch Intern Med. 1983 May;143(5):960-3. Arch Intern Med. 1983. PMID: 6089682 Review.
Cited by
-
Host genetics and tuberculosis: Theory of genetic polymorphism and tuberculosis.Lung India. 2019 May-Jun;36(3):244-252. doi: 10.4103/lungindia.lungindia_146_15. Lung India. 2019. PMID: 31031349 Free PMC article.
-
1,25-Dihydroxyvitamin D3 induces nitric oxide synthase and suppresses growth of Mycobacterium tuberculosis in a human macrophage-like cell line.Infect Immun. 1998 Nov;66(11):5314-21. doi: 10.1128/IAI.66.11.5314-5321.1998. Infect Immun. 1998. PMID: 9784538 Free PMC article.